Company: LIMN
Filing Date: 2025-05-06
Form Type: 8-K
Source: 0001104659-25-045127
Chunk: 6

Company: Liminatus Pharma, Inc.
Filing Date: 2025-05-06
Form: 8-K
Item: Item 9.01
Chunk 6
---
Item 9.01. Financial Statements and Exhibits.

(a) Financial Statements of Businesses
Acquired.

The audited financial statements
of ParentCo for the fiscal years ended December 31, 2024 and 2023, the related notes and report of independent registered public
accounting firm are filed herewith as Exhibit 99.1 and are incorporated herein by reference.

The audited financial statements
of Liminatus for the fiscal years ended December 31, 2024 and 2023, the related notes and report of independent registered public
accounting firm are filed herewith as Exhibit 99.2 and are incorporated herein by reference.

(b) Pro Forma Financial Information.

Certain unaudited pro forma
condensed combined financial information is filed herewith as Exhibit 99.3 and is incorporated herein by reference.

(d) Exhibits.

The following exhibits are
filed as part of, or incorporated by reference into, this Report.

  Exhibit      Description                                                                                                                                                                                           
  No.                                                                                                                                                                                                                
  2.1          Business Combination Agreement, dated November 30, 2022, as amended, by and among Iris Acquisition Corp, Iris Parent Holding Corp., Liminatus Pharma, LLC, Liminatus Pharma Merger Sub, Inc. and ...  
  2.2*         Certificate of Merger of Liminatus Pharma, LLC and Liminatus Pharma Merger Sub, Inc. filed on April 30, 2025.                                                                                         
  2.3*         Certificate of Merger of Iris Acquisition Corp and SPAC Merger Sub, Inc. filed on April 30, 2025.                                                                                                     
  3.1*         Amended and Restated                                                                                                                                                                                  
               Certificate of Incorporation of Iris Parent Holding Corp. (renamed Liminatus Pharma, Inc.) filed on April 30, 2025.                                                                                   
  3.2          Amended and Restated Bylaws of Iris Parent Holding Corp. (renamed Liminatus Pharma, Inc.) (incorporated by reference to Annex I to the proxy statement/prospectus filed with the SEC on February ...  
  4.3          Warrant Agreement, dated as of March 4, 2021, between Continental Stock Transfer & Trust Company and Iris Acquisition Corp (incorporated by reference to Exhibit 4.1 of Form 8-K of Iris Acquisit...  
  4.4*         Assumption of Warrant Agreement